CompoAtlas

NMN 18000 Capsule

Natural health product licensed in Canada

Other names
ARCTIC NATURALS-NMN 18000 Capsule, AVONLEA NATURALS-NMN 18000 Capsule, BENEMAX Health & Wellness-NMN 18000 Capsule, BENEMAX-NMN 18000 Capsule, Benemax Remedies ®-NMN 18000 Capsule, DR. BETHUNE'S CHOICE TM-NMN 18000 Capsule, Elite Naturals Remedies ®-NMN 18000 Capsule, GROUP of 7 NATURALS-NMN 18000 Capsule, POLAR NATURALS ®-NMN 18000 Capsule
Licence holder
NuGale Pharmaceutical Inc.
NPN or DIN-HM
80140088
Status
Active licence
Licence date
11 April 2025
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3-(Aminocarbonyl)-1-(5-O-phosphonato-bêta -D-ribofuranosyl)pyridinium300 mgNot calculated

Non-medicinal ingredients

Maltodextrine, Farine de riz brun, Stéarate de magnésium, Hydroxypropyl méthylcellulose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in the maintenance of good health. A factor in the maintenance of good health and normal growth and development. Helps in energy metabolism and in tissue formation. Helps normal growth and development. Helps to maintain the body's ability to metabolize nutrients. NMN is a NAD+ precursor which is a factor in normal growth and development. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health NMN is a NAD+ precursor which is an important cofactor in energy metabolism.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80140088

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line